Iodopovidone: An inexpensive and effective agent for chemical pleurodesis

Lung Cancer

Volumn 55, Issue 2, 2007, Pages 253-254

  Agarwal, Ritesh ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN; DOXYCYCLINE; FIBROBLAST GROWTH FACTOR; POVIDONE IODINE; TALC; TETRACYCLINE; TETRACYCLINE DERIVATIVE; TRANSFORMING GROWTH FACTOR BETA;

ADULT RESPIRATORY DISTRESS SYNDROME; CYTOTOXICITY; DRUG COST; DRUG HYPERSENSITIVITY; HUMAN; HYPERTHYROIDISM; INDUCED HYPOTENSION; LETTER; LUNG SURGERY; NONHUMAN; PH; PLEURA EFFUSION; PLEURODESIS; PNEUMOTHORAX; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SIDE EFFECT; THORACOSCOPY; THORAX DRAINAGE; THORAX PAIN; THYROTOXICOSIS;

DRAINAGE; HUMANS; PALLIATIVE CARE; PLEURAL EFFUSION, MALIGNANT; PLEURODESIS; POVIDONE-IODINE; TALC; THORACOSCOPY; TUMOR MARKERS, BIOLOGICAL;

EID: 33846034804     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2006.10.011     Document Type: Letter

References (17)

1. Neragi-Miandoab S. Malignant pleural effusion, current and evolving approaches for its diagnosis and management. Lung Cancer 54 (2006) 1-9
2. Lee Y.C., Baumann M.H., Maskell N.A., Waterer G.W., Eaton T.E., Davies R.J., et al. Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists. Chest 124 (2003) 2229-2238
3. Antunes G., Neville E., Duffy J., and Ali N. BTS guidelines for the management of malignant pleural effusions. Thorax 58 Suppl. 2 (2003) ii29-ii38
4. Walker-Renard P.B., Vaughan L.M., and Sahn S.A. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 120 (1994) 56-64
5. Kennedy L., and Sahn S.A. Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest 106 (1994) 1215-1222
6. Shaw P., and Agarwal R. Pleurodesis for malignant pleural effusions. Cochrane Database Syst Rev (2004) CD002916
7. Tan C., Sedrakyan A., Browne J., Swift S., and Treasure T. The evidence on the effectiveness of management for malignant pleural effusion: a systematic review. Eur J Cardiothorac Surg 29 (2006) 829-838
8. Fraticelli A., Robaglia-Schlupp A., Riera H., Monjanel-Mouterde S., Cau P., and Astoul P. Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 122 (2002) 1737-1741
9. Montes J.F., Ferrer J., Villarino M.A., Baeza B., Crespo M., and Garcia-Valero J. Influence of talc dose on extrapleural talc dissemination after talc pleurodesis. Am J Respir Crit Care Med 168 (2003) 348-355
10. Brant A., and Eaton T. Serious complications with talc slurry pleurodesis. Respirology 6 (2001) 181-185
11. Janssen J.P. Is thoracoscopic talc pleurodesis really safe?. Monaldi Arch Chest Dis 61 (2004) 35-38
12. Agarwal R., Aggarwal A.N., and Gupta D. Efficacy and safety of iodopovidone pleurodesis through tube thoracostomy. Respirology 11 (2006) 105-108
13. Agarwal R., Aggarwal A.N., Gupta D., and Jindal SK. Efficacy and safety of iodopovidone in chemical pleurodesis: a meta-analysis of observational studies. Respir Med 100 (2006) 2043-2047
14. Estrada Salo G., Farina Rios C., Fibla Alfara J.J., Gomez Sebastian G., Unzueta M.C., and Leon Gonzalez C. Spontaneous pneumothorax: pleurodesis with an iodo-povidone hydroalcoholic solution. Arch Bronconeumol 39 (2003) 171-174
15. Brissaud O., Desfrere L., Mohsen R., Fayon M., and Demarquez J.L. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed 88 (2003) F531-F533
16. Antony V.B., Nasreen N., Mohammed K.A., Sriram P.S., Frank W., Schoenfeld N., et al. Talc pleurodesis: basic fibroblast growth factor mediates pleural fibrosis. Chest 126 (2004) 1522-1528
17. Gary Lee Y.C., Teixeira L.R., Devin C.J., Vaz M.A., Vargas F.S., Thompson P.J., et al. Transforming growth factor-beta2 induces pleurodesis significantly faster than talc. Am J Respir Crit Care Med 163 (2001) 640-644